Premium
Dopaminergic response in Parkinsonian phenotype of Machado‐Joseph disease
Author(s) -
Buhmann Carsten,
Bussopulos Alexandra,
Oechsner Matthias
Publication year - 2003
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.10322
Subject(s) - levodopa , dopaminergic , dopamine , neuroscience , dopamine receptor , cerebellar ataxia , dopamine receptor d2 , machado–joseph disease , parkinson's disease , psychology , dopamine agonist , degenerative disease , medicine , central nervous system disease , ataxia , disease , spinocerebellar ataxia
We report on a patient with genetically proven Machado‐Joseph Disease (MJD) presenting with signs indistinguishable from Parkinson's disease (PD), including levodopa response and typical levodopa‐induced motor fluctuations. Only after 10 years of prolonged benefit from levodopa and different dopamine agonists (DA), the patient developed cerebellar ataxia and pyramidal signs. Preferential D3‐receptor–stimulating dopamine agonists especially showed a benefit at the time, when D2 receptor binding was reduced in IBZM SPECT. This is the first report of a meaningful response to DA in MJD. © 2002 Movement Disorder Society